Selective targeting of human TET1 by cyclic peptide inhibitors: Insights from biochemical profiling

Bioorg Med Chem. 2024 Feb 1:99:117597. doi: 10.1016/j.bmc.2024.117597. Epub 2024 Jan 12.

Abstract

Ten-Eleven Translocation (TET) enzymes are Fe(II)/2OG-dependent oxygenases that play important roles in epigenetic regulation, but selective inhibition of the TETs is an unmet challenge. We describe the profiling of previously identified TET1-binding macrocyclic peptides. TiP1 is established as a potent TET1 inhibitor (IC50 = 0.26 µM) with excellent selectivity over other TETs and 2OG oxygenases. TiP1 alanine scanning reveals the critical roles of Trp10 and Glu11 residues for inhibition of TET isoenzymes. The results highlight the utility of the RaPID method to identify potent enzyme inhibitors with selectivity over closely related paralogues. The structure-activity relationship data generated herein may find utility in the development of chemical probes for the TETs.

MeSH terms

  • DNA Methylation
  • DNA-Binding Proteins / metabolism
  • Dioxygenases* / metabolism
  • Epigenesis, Genetic
  • Humans
  • Mixed Function Oxygenases / metabolism
  • Peptides, Cyclic*
  • Proto-Oncogene Proteins

Substances

  • Peptides, Cyclic
  • DNA-Binding Proteins
  • Mixed Function Oxygenases
  • Dioxygenases
  • TET1 protein, human
  • Proto-Oncogene Proteins